Cargando…

Production of EV71 vaccine candidates

Enterovirus 71 (EV71) is now recognized as an emerging neurotropic virus in Asia and with Coxsackie virus (CV) it is the other major causative agent of hand-foot-mouth diseases (HFMD). Effective medications and/or prophylactic vaccines against HFMD are urgently needed. From a scientific (the feasibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chong, Pele, Hsieh, Shih-Yang, Liu, Chia-Chyi, Chou, Ai-Hsiang, Chang, Jui-Yuan, Wu, Suh-Chin, Liu, Shih-Jen, Chow, Yen-Hung, Su, Ih-Jen, Klein, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656065/ https://www.ncbi.nlm.nih.gov/pubmed/22992566 http://dx.doi.org/10.4161/hv.21739

Ejemplares similares

Immunological Evaluation and Comparison of Different EV71 Vaccine Candidates
por: Chou, Ai-Hsiang, et al.
Publicado: (2012)

Delivery of Human EV71 Receptors by Adeno-Associated Virus Increases EV71 Infection-Induced Local Inflammation in Adult Mice
por: Hsiao, Hung-Bo, et al.
Publicado: (2014)

Immunogenicity Studies of Bivalent Inactivated Virions of EV71/CVA16 Formulated with Submicron Emulsion Systems
por: Lin, Chih-Wei, et al.
Publicado: (2014)

Formalin-Inactivated EV71 Vaccine Candidate Induced Cross-Neutralizing Antibody against Subgenotypes B1, B4, B5 and C4A in Adult Volunteers
por: Chou, Ai-Hsiang, et al.
Publicado: (2013)

Human SCARB2-Mediated Entry and Endocytosis of EV71
por: Lin, Yi-Wen, et al.
Publicado: (2012)

Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques
por: Liu, Chia-Chyi, et al.
Publicado: (2014)

Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates
por: Chou, Ai-Hsiang, et al.
Publicado: (2012)

Challenges to Licensure of Enterovirus 71 Vaccines
por: Lee, Min-Shi, et al.
Publicado: (2012)

Immunological and Biochemical Characterization of Coxsackie Virus A16 Viral Particles
por: Chong, Pele, et al.
Publicado: (2012)

The uncoating of EV71 in mature late endosomes requires CD-M6PR
por: Ohka, Seii, et al.
Publicado: (2022)

The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus
por: Wu, Chia-Ying, et al.
Publicado: (2019)

EV-A71 induced IL-1β production in THP-1 macrophages is dependent on NLRP3, RIG-I, and TLR3
por: Huang, Hsing-I, et al.
Publicado: (2022)

Induction of SOCS Expression by EV71 Infection Promotes EV71 Replication
por: Gao, Wenying, et al.
Publicado: (2020)

Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71
por: Lin, Yi-Wen, et al.
Publicado: (2013)

Recombinant lipoprotein-based vaccine candidates against C. difficile infections
por: Huang, Jui-Hsin, et al.
Publicado: (2015)

Complete Genome Sequence of Human Enterovirus Strain 71 (EV71/Taipei/3118/2011), Isolated from a Patient in Taiwan
por: Lin, Chia-Pei, et al.
Publicado: (2015)

Recombinant Adeno-Vaccine Expressing Enterovirus 71-Like Particles against Hand, Foot, and Mouth Disease
por: Tsou, Yueh-Liang, et al.
Publicado: (2015)

A Purified Recombinant Lipopeptide as Adjuvant for Cancer Immunotherapy
por: Song, Ying-Chyi, et al.
Publicado: (2014)

The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo
por: Ren, Peijun, et al.
Publicado: (2014)

Mutations in the non-structural protein region contribute to intra-genotypic evolution of enterovirus 71
por: Huang, Sheng-Wen, et al.
Publicado: (2014)

Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2014)

Identification of synthetic vaccine candidates against SARS CoV infection
por: Lien, Shu-Pei, et al.
Publicado: (2007)

Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
por: Liu, Shih-Jen, et al.
Publicado: (2006)

Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Mutations in VP1 and 5′-UTR affect enterovirus 71 virulence
por: Chang, Ching-Kun, et al.
Publicado: (2018)

Inhibition of EV71 by curcumin in intestinal epithelial cells
por: Huang, Hsing-I, et al.
Publicado: (2018)

Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide
por: Shen, Kuan-Yin, et al.
Publicado: (2014)

Author Correction: Mutations in VP1 and 5′-UTR affect enterovirus 71 virulence
por: Chang, Ching-Kun, et al.
Publicado: (2018)

Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signaling
por: Lai, Rai-Hua, et al.
Publicado: (2022)

Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children
por: Arthur Huang, Kuan-Ying, et al.
Publicado: (2017)

Purification and Characterization of Enterovirus 71 Viral Particles Produced from Vero Cells Grown in a Serum-Free Microcarrier Bioreactor System
por: Liu, Chia-Chyi, et al.
Publicado: (2011)

Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1
por: Tan, Chee Wah, et al.
Publicado: (2012)

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

Protective effect of enterovirus-71 (EV71) virus-like particle vaccine against lethal EV71 infection in a neonatal mouse model
por: CAO, LEI, et al.
Publicado: (2015)

EV71 vaccine, an invaluable gift for children
por: Liang, Zhenglun, et al.
Publicado: (2014)

Muscle Tissue Damage and Recovery After EV71 Infection Correspond to Dynamic Macrophage Phenotypes
por: Lu, Mei-Yi, et al.
Publicado: (2021)

A clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2016)

Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model
por: Liou, An-Ting, et al.
Publicado: (2019)

EV71 Infection Induces IFNβ Expression in Neural Cells
por: Huang, Hsing-I, et al.
Publicado: (2019)

Honeysuckle Aqueous Extracts Induced let-7a Suppress EV71 Replication and Pathogenesis In Vitro and In Vivo and Is Predicted to Inhibit SARS-CoV-2
por: Lee, Ying-Ray, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rtkbqrg11cg0iag48vnleb279s